Inicio › Cáncer metastásico › Míchigan › Grand Rapids
Ensayos clínicos de Cáncer metastásico en Grand Rapids, MI
22 estudios para Cáncer metastásico buscan participantes en centros de Grand Rapids y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
ReclutandoFase 2
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Trinity Health Grand Rapids Hospital, Grand Rapids
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
ReclutandoFase 1
- South Texas Accelerated Research Therapeutics (START), Grand Rapids
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
ReclutandoFase 1
- START Midwest Cancer and Hematology Centers of W Michigan, Grand Rapids
A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours
ReclutandoFase 1/2
- START Midwest, Grand Rapids
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
ReclutandoFase 1
- ALX Center 3, Grand Rapids
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
ReclutandoFase 2/3
- The Cancer and Hematology Centers, Grand Rapids
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
ReclutandoFase 3
- The Cancer & Hematology Centers, Grand Rapids
- The Cancer & Hematology Centers, Grand Rapids
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
ReclutandoFase 1
- BAMF Health Inc., Grand Rapids
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
ReclutandoFase 1/2
- START Midwest, Grand Rapids
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
ReclutandoFase 1/2
- START Midwest, Grand Rapids
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- Clinical Study Site, Grand Rapids
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
ReclutandoFase 3
- The Cancer & Hematology Centers, Grand Rapids
A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor Therapies
ReclutandoFase 1/2
- South Texas Accelerated Research Therapeutics (START) - Midwest, Grand Rapids
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
ReclutandoFase 1
- South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids
A Study of MGC026 in Participants With Advanced Solid Tumors
ReclutandoFase 1
- START Midwest, Grand Rapids
A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
ReclutandoFase 1
- START Midwest, Grand Rapids
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
ReclutandoFase 1/2
- Crinetics Study Site, Grand Rapids
CT-95 in Advanced Cancers Associated With Mesothelin Expression
ReclutandoFase 1
- Context Investigational Site, Grand Rapids
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
ReclutandoFase 1
- START Midwest, Grand Rapids
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
ReclutandoFase 1/2
- Start Midwest Cancer Research, Grand Rapids
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
ReclutandoEstudio observacional
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- START Midwest, Grand Rapids
Ensayos de Cáncer metastásico en otras ciudades
- Houston, TX104 estudios
- New York City, NY93 estudios
- Nashville, TN70 estudios
- Boston, MA63 estudios
- Los Angeles, CA57 estudios
- St. Louis, MO54 estudios
- Arlington, VA53 estudios
- Philadelphia, PA46 estudios
- Chicago, IL45 estudios
- San Antonio, TX44 estudios
- Washington, DC43 estudios
- Dallas, TX42 estudios
Otros estudios en Grand Rapids
- Cáncer de pulmón de células no pequeñas44 estudios
- Cáncer del colon y del recto40 estudios
- Cáncer (todos los tipos)28 estudios
- Cáncer de seno26 estudios
- Cáncer de ovario24 estudios
- Cáncer de próstata19 estudios
- Cáncer de endometrio18 estudios
- Cáncer de estómago18 estudios
- Cáncer de páncreas18 estudios
- Melanoma17 estudios
- Carcinoma de células escamosas de cabeza y cuello15 estudios
- Cáncer de mama triple negativo15 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.